Baseline characteristics of patients
| Baseline characteristics of patients | Prevalence (n=33) |
|---|---|
| Age, mean±SD (years) | 62.4±8.36 |
| Clinical characteristics, n (%) | |
| Male | 25 (75.8) |
| Female | 8 (24.2) |
| Hypertension | 17 (51.5) |
| Hypercholesterolaemia | 23 (69.7) |
| Diabetes mellitus | 3 (9.1) |
| Current smoker | 4 (12.1) |
| Positive family history for CHD | 16 (48.5) |
| Single vessel disease | 26 (78.8) |
| Previous MI | 9 (27.3) |
| Previous stroke | 1 (3.03) |
| Preserved LV function | 32 (97.0) |
| Heart failure | 0 (0.0) |
| Previous PCI or CABG | 3 (9.1) |
| Drug treatment, n (%) | |
| Aspirin | 33 (100.0) |
| Clopidogrel | 33 (100.0) |
| ACE inhibitor | 17 (51.5) |
| Angiotensin receptor blocker | 4 (12.1) |
| β-blocker | 29 (87.9) |
| Calcium channel blocker | 13 (39.4) |
| Diuretic | 16 (48.5) |
| Nitrate | 16 (48.5) |
| Nicorandil | 6 (18.2) |
| Statin | 30 (90.9) |
CHD, coronary heart disease; PCI, percutaneous coronary intervention; MI, myocardial infarction; LV, left ventricular; CABG, coronary artery bypass graft.